← FDA DRUG APPROVALS
FDA ANDA · ANDA209610
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sponsor: PADAGIS ISRAEL
APPLICATION
ANDA209610
TYPE
ANDA
ORIGINAL APPROVAL
2024-08-20
LATEST ACTION
2024-08-20
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEPrescription
BENZOYL PEROXIDE 3.75%, CLINDAMYCIN PHOSPHATE EQ 1.2% BASE · GEL · TOPICAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.